FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:676 September 8, 1994 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Dr. Brennan's argument for better disclosure of collaboration between pharmaceutical companies and academic medicine (see the Sounding Board article elsewhere in this issue) merits serious consideration. However, the portrayal of the part public-relations companies play in such collaborations -- in particular, the writing of editorials -- is misleading.

One role of public-relations companies in this regard is to help researchers communicate their thoughts and opinions. We offer expertise in writing and editing to facilitate and expedite the expression of the author's viewpoint, with whatever assistance he or she chooses. All the physicians who work with us have . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.